Clinical Trial Update: Pharmacokinetics of FDL169 in Healthy Female Subjects [Phase 1]

View source ↗

Summary

This Phase 1 pharmacokinetic study of FDL169 in healthy female subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• FDL169

Snippet

Sponsor: Flatley Discovery Lab LLC | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED